Voyageur Pharmaceuticals (CVE:VM) Sets New 12-Month Low – Here’s Why

Voyageur Pharmaceuticals Ltd. (CVE:VM) hit a new 52-week low during mid-day trading on Monday . The company traded as low as C$0.13 and last traded at C$0.13, with a volume of 192568 shares. The stock had previously closed at C$0.15.

Voyageur Pharmaceuticals Stock Down 6.7%

The firm has a 50-day moving average of C$0.16 and a two-hundred day moving average of C$0.16. The company has a quick ratio of 0.84, a current ratio of 0.58 and a debt-to-equity ratio of 2.77. The company has a market capitalization of C$24.98 million, a PE ratio of -7.00 and a beta of 0.78.

Voyageur Pharmaceuticals Company Profile

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. was founded in 2017 and is headquartered in Calgary, Canada.